Rolls-Royce Holdings Plc:企業のM&A・事業提携・投資動向

◆英語タイトル:Rolls-Royce Holdings Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C0699
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:106
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:航空・防衛
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Rolls-Royce Holdings Plc – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Rolls-Royce Holdings Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Rolls-Royce Holdings Plc since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Rolls-Royce Holdings Plc’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Rolls-Royce Holdings Plc. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Rolls-Royce Holdings Plc’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Rolls-Royce Holdings Plc and its subsidiaries since 2007.
- Information about key financial and legal advisors for Rolls-Royce Holdings Plc’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Rolls-Royce Holdings Plc’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
CORPORATE VENTURING 44
Corporate Venturing – Overview 44
Corporate Venturing – Deal reports 45
PARTNERSHIP 48
Partnership – Overview 48
Partnership – Deal reports 49
CAPITAL RAISING 76
Capital Raising – Overview 76
Capital Raising – Deal reports 77
DIVESTMENTS 79
Divestments – Overview 79
Divestments – Deal reports 80
APPENDIX 96
Contact Us 96
About MarketLine Financial Deals Database 96
Deal Definition and Methodology 98
About MarketLine 105

List of Tables
Table 1: Rolls-Royce Holdings plc M&A volume and value trend (2014-YTD2018)
Table 2: Rolls-Royce Holdings plc M&A activity by geography (2014-YTD2018)
Table 3: Rolls-Royce Holdings plc corporate venturing volume and value trend (2014-YTD2018)
Table 4: Rolls-Royce Holdings plc corporate venturing by geography (2014-YTD2018)
Table 5: Rolls-Royce Holdings plc partnership volume and value trend (2014-YTD2018)
Table 6: Rolls-Royce Holdings plc partnership trend by key deal type (2014-YTD2018)
Table 7: Rolls-Royce Holdings plc capital raising volume and value trend (2014-YTD2018)
Table 8: Rolls-Royce Holdings plc capital raising by deal type (2014-YTD2018)
Table 9: Rolls-Royce Holdings plc divestments volume and value trend (2014-YTD2018)
Table 10: Rolls-Royce Holdings plc divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Rolls-Royce Holdings plc M&A volume and value trend (2014-YTD2018)
Figure 2: Rolls-Royce Holdings plc M&A activity by geography (2014-YTD2018)
Figure 3: Rolls-Royce Holdings plc corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Rolls-Royce Holdings plc corporate venturing by geography (2014-YTD2018)
Figure 5: Rolls-Royce Holdings plc partnership volume and value trend (2014-YTD2018)
Figure 6: Rolls-Royce Holdings plc partnership trend by key deal type (2014-YTD2018)
Figure 7: Rolls-Royce Holdings plc capital raising volume and value trend (2014-YTD2018)
Figure 8: Rolls-Royce Holdings plc capital raising by deal type (2014-YTD2018)
Figure 9: Rolls-Royce Holdings plc divestments volume and value trend (2014-YTD2018)
Figure 10: Rolls-Royce Holdings plc divestments by geography (2014-YTD2018)

★海外企業調査レポート[Rolls-Royce Holdings Plc:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kissei Pharmaceutical Co Ltd (4547):製薬・医療:M&Aディール及び事業提携情報
    Summary Kissei Pharmaceutical Co Ltd (Kissei) discovers, manufactures and sells a range of innovative pharmaceutical products and develops. The company's pharmaceutical products include urological medicine, metabolic endocrinology medicine, drugs for kidney and dialysis department, drug for obstetri …
  • Oaks Hotels & Resorts Limited
    Oaks Hotels & Resorts Limited - Strategy, SWOT and Corporate Finance Report Summary Oaks Hotels & Resorts Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Devon Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Devon Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Devon Energy Corp (Devon Energy) is an independent energy company. The company carries out exploration, development, and production of oil, natural gas and natural gas liquids (NGLs). It has its op …
  • Sonic Healthcare Ltd (SHL)-医療機器分野:企業M&A・提携分析
    Summary Sonic Healthcare Ltd (Sonic Healthcare) Sonic Healthcare is a medical diagnostics company that provides laboratory and diagnostic imaging services. The company provides laboratory medicine, pathology, radiology, diagnostic imaging and primary care medical services. It operates Australia's la …
  • Asuragen Inc:医療機器:M&Aディール及び事業提携情報
    Summary Asuragen Inc (Asuragen) is an oncology molecular diagnostic company that provides laboratory medicine solutions. The company offers products such as amplidex, quantidex, and custom reagents. It provides custom and companion diagnostic services, which include commercialization, product approv …
  • Strongbridge Biopharma plc (SBBP):製薬・医療:M&Aディール及び事業提携情報
    Summary Strongbridge Biopharma Plc (Strongbridge Biopharma), formerly Cortendo Plc is a commercial-stage biopharmaceutical company that develops and commercializes therapies for rare diseases. The company’s marketed product KEVEYIS (dichlorphenamide) is indicated for the treatment of hypokalemic, hy …
  • ICON Plc (ICLR):製薬・医療:M&Aディール及び事業提携情報
    Summary ICON plc (ICON) is a contract research organization (CRO) that provides outsourced development services to the biotechnology, pharmaceutical and medical device industries worldwide. It provides a range of specialized services that span the entire lifecycle of product development. The company …
  • Asiana Airlines Inc.:企業の戦略・SWOT・財務情報
    Asiana Airlines Inc. - Strategy, SWOT and Corporate Finance Report Summary Asiana Airlines Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Peabody Energy Corp:企業の戦略・SWOT・財務情報
    Peabody Energy Corp - Strategy, SWOT and Corporate Finance Report Summary Peabody Energy Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Altacor Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Altacor Ltd (Altacor) is an ophthalmology company that develops and markets orphan products for chronic eye conditions. The company offers prescription and retail ophthalmology products. Its products include dry eye prescription products; dry eye retail products; products for the treatment o …
  • Seikagaku Corp (4548):製薬・医療:M&Aディール及び事業提携情報
    Summary Seikagaku Corp (Seikagaku) is a manufacturer and supplier of pharmaceuticals and medical devices. The company offers products such as pharmaceuticals and medical devices, bulk products, endotoxin-detecting reagents and oral care products. It manufactures and markets pharmaceutical products c …
  • Marafiq:企業の戦略的SWOT分析
    Marafiq - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Flatiron Health Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Flatiron Health Inc (Flatiron Health) a subsidiary of F. Hoffmann-La Roche Ltd, is a healthcare technology company which develops a learning healthcare system in oncology. The company offers a web-based business and clinical intelligence data platform that integrates and structures disparate …
  • Red Robin Gourmet Burgers Inc:企業の戦略・SWOT・財務情報
    Red Robin Gourmet Burgers Inc - Strategy, SWOT and Corporate Finance Report Summary Red Robin Gourmet Burgers Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Dunkin’ Brands Group Inc:企業の戦略・SWOT・財務情報
    Dunkin' Brands Group Inc - Strategy, SWOT and Corporate Finance Report Summary Dunkin' Brands Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Shun Tak Holdings Ltd (242):企業の財務・戦略的SWOT分析
    Shun Tak Holdings Ltd (242) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Z Energy Ltd
    Z Energy Ltd - Strategy, SWOT and Corporate Finance Report Summary Z Energy Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • UnitedHealth Group Inc (UNH):企業の財務・戦略的SWOT分析
    UnitedHealth Group Inc (UNH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Sawai Pharmaceutical Co Ltd (4555):製薬・医療:M&Aディール及び事業提携情報
    Summary Sawai Pharmaceutical Co Ltd (Sawai Pharmaceutical) manufactures, sells, imports and exports ethical drugs and proprietary drugs. The company's products include cardiovascular drugs, antihyperlipidemic agents, diabetes drugs, anticancer drugs, and OTC drugs. It provides products in the form o …
  • SymBio Pharmaceuticals Ltd (4582):製薬・医療:M&Aディール及び事業提携情報
    Summary SymBio Pharmaceuticals Ltd (SymBio) is a biopharmaceutical company that develops and markets anti-cancer drug candidates. The company develops SyB drugs, treakisym and rigosertib, among others. It offers business development services in areas of oncology, hematology and pain-management areas …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆